3T ADC values in benign neck lesions
Age, y/Sex | Lesion | ADC, × 10−3 mm2/s |
---|---|---|
89/F | Lipomatous hemangiopericytoma | 1.611 ± 0.167 |
45/F | Fibrous dysplasia (F/U-15 y)* | 0.949 ± 0.070 |
22/F | Masseteric hemangioma | 1.842 ± 0.075 |
57/F | Orbital apex aspergillosis | 1.576 ± 0.214 |
77/F | Clival mass stable for 7 y* | 1.915 ± 0.221 |
37/M | Schwannoma (vestibular) | 0.739 ± 0.079 |
34/F | Schwannoma (vestibular) | 1.566 ± 0.237 |
36/F | Schwannoma (vestibular) | 1.742 ± 0.181 |
58/M | Schwannoma (vestibular) | 1.922 ± 0.186 |
66/M | Schwannoma (jugular foramen) | 2.080 ± 0.332 |
39/F | Schwannoma (mandibular nerve) | 2.033 ± 0.521 |
33/M | Oncocytoma (parotid) | 2.150 ± 0.004 |
62/M | Meningioma (cavernous sinus) (F/U of 2 y)* | 1.041 ± 0.158 |
58/M | Meningioma (cavernous sinus) (F/U of 3 y)* | 1.512 ± 0.462 |
29/F | Meningioma (jugular foramen) | 0.669 ± 0.128 |
41/F | Glomus jugulare | 1.379 ± 0.144 |
31/F | Sarcoidosis (right cerebellopontine angle mass) (F/U 3 y)* | 0.863 ± 0.151 |
Note:—F/U indicates follow-up duration; ADC, apparent diffusion coefficient; F, female; M, male.
* No tissue confirmation was obtained.